Breaking News

Onyx Invests in Continuous Flow Technology

June 23, 2014

Expands GMP manufacturing services for APIs

Onyx Scientific is investing in continuous flow manufacturing to offer clients alternatives during product research and development programs and to help overcome time-consuming and costly processes of API batch manufacturing. Onyx is also expanding its GMP capability for its API manufacturing services.
Denise Bowser, commercial director at Onyx Scientific, said, “The move to continuous flow manufacturing has been seen by a handful of companies in the sector to date so we feel that we are very much at the forefront of technological advances when it comes to the development and production of API.For us, it makes better use of our space, gives us a quicker output and provides greater flexibility in the manufacturing of compounds as well as delivering considerable cost savings, which we can pass onto clients.”
Ms. Bowser added, “Over the last year or so, we’ve felt a surge in demand for GMP manufacturing at our site in Sunderland so have moved to increase capacity by investing in additional vessels to satisfy market demand.The integration of pre- formulation development and GMP manufacturing has really benefited many clients over the last two years and this is a trend that we expect to continue in the future as clients look for smarter ways to develop compounds.”

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO